Story perspectives

Trump Faces Backlash Over Mifepristone Telehealth Prescriptions

4/10/2026

Summary

Story summary

Abortion opponents criticize U.S. President Donald Trump for not acting against online mifepristone prescriptions.
A federal ruling lets telehealth prescriptions continue while the U.S. Food and Drug Administration reviews safety.
Louisiana Attorney General Liz Murrill appeals the decision, arguing irreparable harm to the state.
Abortion rates stay steady despite bans, with telehealth access cited.
The FDA faces pressure to speed its review as anti-abortion activists seek tighter regulations.

1 of 1

Story summary

Abortion opponents criticize U.S. President Donald Trump for not acting against online mifepristone prescriptions.
A federal ruling lets telehealth prescriptions continue while the U.S. Food and Drug Administration reviews safety.
Louisiana Attorney General Liz Murrill appeals the decision, arguing irreparable harm to the state.
Abortion rates stay steady despite bans, with telehealth access cited.
The FDA faces pressure to speed its review as anti-abortion activists seek tighter regulations.